Immunotherapy Conference Features Cutting-edge Research
This week, some of the world’s leading cancer researchers are gathering in Mainz/Frankfurt, Germany for the Third International Cancer...
Tag: immunotherapy
This week, some of the world’s leading cancer researchers are gathering in Mainz/Frankfurt, Germany for the Third International Cancer...
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
A pair of studies published recently in journals of the American Association for Cancer Research bring to our attention...
Three years ago, the American Association for Cancer Research (AACR) launched this blog with a welcome post from Chief...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved expanding the use of pembrolizumab...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
On March 23, the U.S. Food and Drug Administration announced the first-ever approval of a treatment for patients with...
Identifying ways to increase the proportion of patients with melanoma who have clinically meaningful and durable responses to immune...
Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with...
The U.S. Food and Drug Administration (FDA) has approved expanding the use of the immunotherapeutic pembrolizumab (Keytruda) to include...